Obesity

Latest News

Tesomet Receives Orphan Drug Status for Hypothalamic Obesity

By

Brian Park, PharmD

Tesomet is an investigational fixed-dose combination therapy of tesofensine, a triple monoamine reuptake inhibitor, and metoprolol, a beta-1 selective blocker.

Systematic Review of Dietary Supplements, Alternative Therapies for Weight Loss

By

Maria Arini Lopez, PT, DPT, CSCS, CMTPT

Investigators assess the efficacy of dietary supplements and alternative therapies for weight loss.

Digital Self-Monitoring Effective for Weight Loss, Healthy Lifestyle

Digital self-monitoring of physical activity and diet is an effective intervention to support weight loss in adults with obesity or overweight.

NAPNAP Updates Position Statement on Childhood Obesity

By

Jeanelle Jacobs

The purpose of the updated statement stems from NAPNAP’s commitment to encouraging healthy lifestyles to establish a foundation of optimal health.

Adipose Tissue and the Pathogenesis of Insulin Resistance in Patients With Obesity and NAFLD

By

Virginia A. Schad, PharmD, RPh

Researchers investigated the underlying mechanisms responsible for insulin resistance in patients with obesity and NAFLD.

Obesity Linked to Lower Death Risk in mCRPC

By

Jody A. Charnow

Obesity in men with metastatic castration-resistant prostate cancer is associated with decreased risks for all-cause and cancer-specific mortality compared with overweight and normal-weight men.

Orlistat Therapy for Obesity Linked to Fewer Major Adverse Cardiovascular Events

By

Rita Aghjayan

A team of UK-based investigators explored the long-term cardiovascular outcomes in patients with obesity who were administered orlistat therapy.

Obesity Tied to Long-Term COVID-19 Complications

Moderate and severe obesity is associated with a greater risk for postacute sequelae of COVID-19.

Bariatric Surgery Beneficial for Class 1 Obesity

For individuals with class 1 obesity, bariatric surgery is effective for weight loss and comorbidity resolution.

Obesity-Related Outcomes Up for Metabolically Healthy Obese

“Metabolically healthy obesity” is associated with an increased risk for obesity-related outcomes, including incident diabetes, ASCVD, and heart failure compared with metabolically healthy individuals without obesity.

Ethnicity-Based Body Mass Index Cutoffs for Type 2 Diabetes Risk

By

Jessica Nye, PhD

Investigators identified body mass index cutoffs for obesity based on the risk of developing type 2 diabetes among adults from different ethnic populations.